SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006303
Filing Date
2020-05-11
Accepted
2020-05-11 17:07:01
Documents
86
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q neos-20200331x10q.htm 10-Q 2467757
2 EX-10.2 neos-20200331ex102e99aaf.htm EX-10.2 139905
3 EX-10.3 neos-20200331ex1037e87a0.htm EX-10.3 48959
4 EX-31.1 neos-20200331ex3113f1f26.htm EX-31.1 15070
5 EX-31.2 neos-20200331ex31292f50a.htm EX-31.2 15560
6 EX-32.1 neos-20200331ex321d96573.htm EX-32.1 10266
7 GRAPHIC neos20200331ex1037e87a0001.jpg GRAPHIC 56409
  Complete submission text file 0001558370-20-006303.txt   10059496

Data Files

Seq Description Document Type Size
8 EX-101.INS neos-20200331.xml EX-101.INS 1965933
9 EX-101.SCH neos-20200331.xsd EX-101.SCH 74211
10 EX-101.CAL neos-20200331_cal.xml EX-101.CAL 73547
11 EX-101.DEF neos-20200331_def.xml EX-101.DEF 323906
12 EX-101.LAB neos-20200331_lab.xml EX-101.LAB 710673
13 EX-101.PRE neos-20200331_pre.xml EX-101.PRE 564242
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 20865924
SIC: 2834 Pharmaceutical Preparations